Clinical trial
Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach
NCT00627276 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Omega-3 Fatty Acids and Prevention of DCIS and/or ADH: A Translational Approach
- Lead sponsor
- OHSU Knight Cancer Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- November 30, 2013
- Enrollment
- 16 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, precancerous condition